SCHEMBL4900874

SCHEMBL4900874

Cc1ccc(-c2cccc3c4cc(N)c5ccccc5c4c4c5ccccc5c(N)c(-c5ccc(C)cc5)c4c23)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ENPP1 P22413 1/20 0.34
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ PARP1 P09874 1/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ PKM P14618 1/20 0.32
▸ GPR84 Q9NQS5 1/20 0.32
▸ POLB P06746 1/20 0.31
▸ PPARG P37231 1/20 0.31
▸ MCL1 Q07820 1/20 0.31
▸ NR2E3 Q9Y5X4 1/20 0.31
▸ NCOR2 Q9Y618 1/20 0.31
▸ ADORA2A P29274 2/20 0.31
▸ ACHE P22303 1/20 0.31
▸ KIT P10721 2/20 0.31
▸ KDR P35968 2/20 0.31
▸ FLT3 P36888 2/20 0.31
▸ CRHR1 P34998 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18334323 0.75 ENPP1 (0.38) ENPP1MEN1KMT2ANPC1RAB9A
SCHEMBL30266810 0.75 ENPP1 (0.38) ENPP1MEN1KMT2ANPC1RAB9A
SCHEMBL27888667 0.73 NPC1 (0.39) ENPP1MEN1KMT2ANPC1RAB9A
SCHEMBL23625587 0.69 ALDH1A1 (0.54) ENPP1MEN1KMT2ANPC1RAB9A
SCHEMBL17600567 0.68 ADORA2A (0.39) ENPP1MEN1KMT2ANPC1RAB9A
SCHEMBL27979090 0.68 ADORA2A (0.39) ENPP1MEN1KMT2ANPC1RAB9A
SCHEMBL28158641 0.67 ACHE (0.42) MEN1KMT2ARAB9AADORA2AACHE
SCHEMBL7652128 0.67 MEN1 (0.51) ENPP1MEN1KMT2ANPC1RAB9A
SCHEMBL22589050 0.67 MAP4K4 (0.47) ENPP1MEN1KMT2ANPC1RAB9A
SCHEMBL29444809 0.66 ADORA2A (0.40) ENPP1MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080226940-A1 DIBENZO[C,G]TRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2008-09-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080226940-A1 DIBENZO[C,G]TRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME JUP, EED, L1CAM ENPP1 1192/4885MEN1 3695/4885KMT2A 2893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback